Loading…

Characterization of PacMetUT1, a recently isolated human prostate cancer cell line

BACKGROUND Existing prostate cancer cell lines have limitations. METHODS Cells were characterized using Western blotting, immunohistochemistry, invasion into Matrigel, and by studying xenograft tumors. RESULTS We describe a cell line (PacMetUT1) isolated from a lymph node of a 57‐year‐old male with...

Full description

Saved in:
Bibliographic Details
Published in:The Prostate 2008-06, Vol.68 (8), p.883-892
Main Authors: Troyer, D.A., Tang, Y., Bedolla, R., Adhvaryu, S.G., Thompson, I.M., Abboud-Werner, S., Sun, L.-Z., Friedrichs, W.E., deGraffenried, L.A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2958-8e6ada321ee44a9f99f2286d2c5f01bf261714af28c0b305be2a572bc8e886b93
cites cdi_FETCH-LOGICAL-c2958-8e6ada321ee44a9f99f2286d2c5f01bf261714af28c0b305be2a572bc8e886b93
container_end_page 892
container_issue 8
container_start_page 883
container_title The Prostate
container_volume 68
creator Troyer, D.A.
Tang, Y.
Bedolla, R.
Adhvaryu, S.G.
Thompson, I.M.
Abboud-Werner, S.
Sun, L.-Z.
Friedrichs, W.E.
deGraffenried, L.A.
description BACKGROUND Existing prostate cancer cell lines have limitations. METHODS Cells were characterized using Western blotting, immunohistochemistry, invasion into Matrigel, and by studying xenograft tumors. RESULTS We describe a cell line (PacMetUT1) isolated from a lymph node of a 57‐year‐old male with prostate cancer. Compared to existing prostate cancer cell lines, the growth rate of PacMetUT1 xenograft tumors is slower with tumors occurring at injection sites and with metastases to lung and liver. Androgen receptor (AR) was detected in vivo by Western blotting and the cells responded to methyltrienolone (R1881). PacMetUT1 cells are more invasive in Matrigel than DU‐145, PC‐3, and LNCaP cells, and showed greater anchorage‐independent growth in soft agar. The cells do not express prostate specific antigen (PSA) in vitro or in xenografts. However, the green fluorescent protein (GFP) gene was introduced and stably expressed in PacMetUT1 cells, allowing tumor imaging in vivo. Xenograft tumors show epithelial features and are positive for keratin, epithelial membrane antigen, EGF receptor, and E cadherin. In contrast, fibroblast markers vimentin, desmin, and Factor VIII, were negative. Karyotyping showed losses of 6p, 7q, 8p, 18q, and 22q, and gains of 8q and 9q; additional genetic material was observed at 2q and 12p. CONCLUSION The PacMetUT1 cell line allows metastases to be assessed using a single animal model. Because of its slower growth, PacMetUT1 more closely mimics the human disease. Studies of tumor progression or metastasis can be conducted over a longer period of time. Prostate 68:883–892, 2008. © 2008 Wiley‐Liss, Inc.
doi_str_mv 10.1002/pros.20758
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69151148</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69151148</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2958-8e6ada321ee44a9f99f2286d2c5f01bf261714af28c0b305be2a572bc8e886b93</originalsourceid><addsrcrecordid>eNp9kM1OwzAQhC0EglK48ADIJw6IgNeJE-cIEVAEBcSP4GZt3I0IpAnYqaA8PSktcOO0Wumb2dlhbAvEPgghD15d4_elSJReYj0QaRIIEall1hMyEUEEYbLG1r1_FqLDhVxla6DDGCKQPXaTPaFD25IrP7Etm5o3Bb9GO6T2_g72OHJHluq2mvLSNxW2NOJPkzHWfHa17XZusbbkuKWq4lVZ0wZbKbDytLmYfXZ_cnyXDYKLq9Oz7PAisDJVOtAU4whDCURRhGmRpoWUOh5JqwoBeSFjSCDCQmor8lConCSqROZWk9ZxnoZ9tjP37ZK8Tci3Zlz6WQqsqZl4E6egACLdgbtz0HaRvaPCvLpyjG5qQJhZg2b2i_lusIO3F66TfEyjP3RRWQfAHHgvK5r-Y2Wub65uf0yDuab0LX38atC9mDgJE2UeLk_NUA2PzrPHgcnCLxrFiuo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69151148</pqid></control><display><type>article</type><title>Characterization of PacMetUT1, a recently isolated human prostate cancer cell line</title><source>Wiley</source><creator>Troyer, D.A. ; Tang, Y. ; Bedolla, R. ; Adhvaryu, S.G. ; Thompson, I.M. ; Abboud-Werner, S. ; Sun, L.-Z. ; Friedrichs, W.E. ; deGraffenried, L.A.</creator><creatorcontrib>Troyer, D.A. ; Tang, Y. ; Bedolla, R. ; Adhvaryu, S.G. ; Thompson, I.M. ; Abboud-Werner, S. ; Sun, L.-Z. ; Friedrichs, W.E. ; deGraffenried, L.A.</creatorcontrib><description>BACKGROUND Existing prostate cancer cell lines have limitations. METHODS Cells were characterized using Western blotting, immunohistochemistry, invasion into Matrigel, and by studying xenograft tumors. RESULTS We describe a cell line (PacMetUT1) isolated from a lymph node of a 57‐year‐old male with prostate cancer. Compared to existing prostate cancer cell lines, the growth rate of PacMetUT1 xenograft tumors is slower with tumors occurring at injection sites and with metastases to lung and liver. Androgen receptor (AR) was detected in vivo by Western blotting and the cells responded to methyltrienolone (R1881). PacMetUT1 cells are more invasive in Matrigel than DU‐145, PC‐3, and LNCaP cells, and showed greater anchorage‐independent growth in soft agar. The cells do not express prostate specific antigen (PSA) in vitro or in xenografts. However, the green fluorescent protein (GFP) gene was introduced and stably expressed in PacMetUT1 cells, allowing tumor imaging in vivo. Xenograft tumors show epithelial features and are positive for keratin, epithelial membrane antigen, EGF receptor, and E cadherin. In contrast, fibroblast markers vimentin, desmin, and Factor VIII, were negative. Karyotyping showed losses of 6p, 7q, 8p, 18q, and 22q, and gains of 8q and 9q; additional genetic material was observed at 2q and 12p. CONCLUSION The PacMetUT1 cell line allows metastases to be assessed using a single animal model. Because of its slower growth, PacMetUT1 more closely mimics the human disease. Studies of tumor progression or metastasis can be conducted over a longer period of time. Prostate 68:883–892, 2008. © 2008 Wiley‐Liss, Inc.</description><identifier>ISSN: 0270-4137</identifier><identifier>EISSN: 1097-0045</identifier><identifier>DOI: 10.1002/pros.20758</identifier><identifier>PMID: 18361412</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Cell Line, Tumor ; Cell Proliferation ; Cyclin-Dependent Kinase Inhibitor p21 - metabolism ; Humans ; Immunohistochemistry ; Karyotyping ; Male ; metastasis ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Metastasis ; prostate cancer ; prostate cancer cell lines ; Prostatic Neoplasms - metabolism ; Prostatic Neoplasms - pathology ; Receptors, Androgen - metabolism ; Transforming Growth Factor beta - pharmacology ; Tumor Suppressor Protein p53 - metabolism</subject><ispartof>The Prostate, 2008-06, Vol.68 (8), p.883-892</ispartof><rights>Copyright © 2008 Wiley‐Liss, Inc.</rights><rights>(c) 2008 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2958-8e6ada321ee44a9f99f2286d2c5f01bf261714af28c0b305be2a572bc8e886b93</citedby><cites>FETCH-LOGICAL-c2958-8e6ada321ee44a9f99f2286d2c5f01bf261714af28c0b305be2a572bc8e886b93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18361412$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Troyer, D.A.</creatorcontrib><creatorcontrib>Tang, Y.</creatorcontrib><creatorcontrib>Bedolla, R.</creatorcontrib><creatorcontrib>Adhvaryu, S.G.</creatorcontrib><creatorcontrib>Thompson, I.M.</creatorcontrib><creatorcontrib>Abboud-Werner, S.</creatorcontrib><creatorcontrib>Sun, L.-Z.</creatorcontrib><creatorcontrib>Friedrichs, W.E.</creatorcontrib><creatorcontrib>deGraffenried, L.A.</creatorcontrib><title>Characterization of PacMetUT1, a recently isolated human prostate cancer cell line</title><title>The Prostate</title><addtitle>Prostate</addtitle><description>BACKGROUND Existing prostate cancer cell lines have limitations. METHODS Cells were characterized using Western blotting, immunohistochemistry, invasion into Matrigel, and by studying xenograft tumors. RESULTS We describe a cell line (PacMetUT1) isolated from a lymph node of a 57‐year‐old male with prostate cancer. Compared to existing prostate cancer cell lines, the growth rate of PacMetUT1 xenograft tumors is slower with tumors occurring at injection sites and with metastases to lung and liver. Androgen receptor (AR) was detected in vivo by Western blotting and the cells responded to methyltrienolone (R1881). PacMetUT1 cells are more invasive in Matrigel than DU‐145, PC‐3, and LNCaP cells, and showed greater anchorage‐independent growth in soft agar. The cells do not express prostate specific antigen (PSA) in vitro or in xenografts. However, the green fluorescent protein (GFP) gene was introduced and stably expressed in PacMetUT1 cells, allowing tumor imaging in vivo. Xenograft tumors show epithelial features and are positive for keratin, epithelial membrane antigen, EGF receptor, and E cadherin. In contrast, fibroblast markers vimentin, desmin, and Factor VIII, were negative. Karyotyping showed losses of 6p, 7q, 8p, 18q, and 22q, and gains of 8q and 9q; additional genetic material was observed at 2q and 12p. CONCLUSION The PacMetUT1 cell line allows metastases to be assessed using a single animal model. Because of its slower growth, PacMetUT1 more closely mimics the human disease. Studies of tumor progression or metastasis can be conducted over a longer period of time. Prostate 68:883–892, 2008. © 2008 Wiley‐Liss, Inc.</description><subject>Cell Line, Tumor</subject><subject>Cell Proliferation</subject><subject>Cyclin-Dependent Kinase Inhibitor p21 - metabolism</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Karyotyping</subject><subject>Male</subject><subject>metastasis</subject><subject>Middle Aged</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Metastasis</subject><subject>prostate cancer</subject><subject>prostate cancer cell lines</subject><subject>Prostatic Neoplasms - metabolism</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Receptors, Androgen - metabolism</subject><subject>Transforming Growth Factor beta - pharmacology</subject><subject>Tumor Suppressor Protein p53 - metabolism</subject><issn>0270-4137</issn><issn>1097-0045</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp9kM1OwzAQhC0EglK48ADIJw6IgNeJE-cIEVAEBcSP4GZt3I0IpAnYqaA8PSktcOO0Wumb2dlhbAvEPgghD15d4_elSJReYj0QaRIIEall1hMyEUEEYbLG1r1_FqLDhVxla6DDGCKQPXaTPaFD25IrP7Etm5o3Bb9GO6T2_g72OHJHluq2mvLSNxW2NOJPkzHWfHa17XZusbbkuKWq4lVZ0wZbKbDytLmYfXZ_cnyXDYKLq9Oz7PAisDJVOtAU4whDCURRhGmRpoWUOh5JqwoBeSFjSCDCQmor8lConCSqROZWk9ZxnoZ9tjP37ZK8Tci3Zlz6WQqsqZl4E6egACLdgbtz0HaRvaPCvLpyjG5qQJhZg2b2i_lusIO3F66TfEyjP3RRWQfAHHgvK5r-Y2Wub65uf0yDuab0LX38atC9mDgJE2UeLk_NUA2PzrPHgcnCLxrFiuo</recordid><startdate>20080601</startdate><enddate>20080601</enddate><creator>Troyer, D.A.</creator><creator>Tang, Y.</creator><creator>Bedolla, R.</creator><creator>Adhvaryu, S.G.</creator><creator>Thompson, I.M.</creator><creator>Abboud-Werner, S.</creator><creator>Sun, L.-Z.</creator><creator>Friedrichs, W.E.</creator><creator>deGraffenried, L.A.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080601</creationdate><title>Characterization of PacMetUT1, a recently isolated human prostate cancer cell line</title><author>Troyer, D.A. ; Tang, Y. ; Bedolla, R. ; Adhvaryu, S.G. ; Thompson, I.M. ; Abboud-Werner, S. ; Sun, L.-Z. ; Friedrichs, W.E. ; deGraffenried, L.A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2958-8e6ada321ee44a9f99f2286d2c5f01bf261714af28c0b305be2a572bc8e886b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Cell Line, Tumor</topic><topic>Cell Proliferation</topic><topic>Cyclin-Dependent Kinase Inhibitor p21 - metabolism</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Karyotyping</topic><topic>Male</topic><topic>metastasis</topic><topic>Middle Aged</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Metastasis</topic><topic>prostate cancer</topic><topic>prostate cancer cell lines</topic><topic>Prostatic Neoplasms - metabolism</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Receptors, Androgen - metabolism</topic><topic>Transforming Growth Factor beta - pharmacology</topic><topic>Tumor Suppressor Protein p53 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Troyer, D.A.</creatorcontrib><creatorcontrib>Tang, Y.</creatorcontrib><creatorcontrib>Bedolla, R.</creatorcontrib><creatorcontrib>Adhvaryu, S.G.</creatorcontrib><creatorcontrib>Thompson, I.M.</creatorcontrib><creatorcontrib>Abboud-Werner, S.</creatorcontrib><creatorcontrib>Sun, L.-Z.</creatorcontrib><creatorcontrib>Friedrichs, W.E.</creatorcontrib><creatorcontrib>deGraffenried, L.A.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Prostate</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Troyer, D.A.</au><au>Tang, Y.</au><au>Bedolla, R.</au><au>Adhvaryu, S.G.</au><au>Thompson, I.M.</au><au>Abboud-Werner, S.</au><au>Sun, L.-Z.</au><au>Friedrichs, W.E.</au><au>deGraffenried, L.A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization of PacMetUT1, a recently isolated human prostate cancer cell line</atitle><jtitle>The Prostate</jtitle><addtitle>Prostate</addtitle><date>2008-06-01</date><risdate>2008</risdate><volume>68</volume><issue>8</issue><spage>883</spage><epage>892</epage><pages>883-892</pages><issn>0270-4137</issn><eissn>1097-0045</eissn><abstract>BACKGROUND Existing prostate cancer cell lines have limitations. METHODS Cells were characterized using Western blotting, immunohistochemistry, invasion into Matrigel, and by studying xenograft tumors. RESULTS We describe a cell line (PacMetUT1) isolated from a lymph node of a 57‐year‐old male with prostate cancer. Compared to existing prostate cancer cell lines, the growth rate of PacMetUT1 xenograft tumors is slower with tumors occurring at injection sites and with metastases to lung and liver. Androgen receptor (AR) was detected in vivo by Western blotting and the cells responded to methyltrienolone (R1881). PacMetUT1 cells are more invasive in Matrigel than DU‐145, PC‐3, and LNCaP cells, and showed greater anchorage‐independent growth in soft agar. The cells do not express prostate specific antigen (PSA) in vitro or in xenografts. However, the green fluorescent protein (GFP) gene was introduced and stably expressed in PacMetUT1 cells, allowing tumor imaging in vivo. Xenograft tumors show epithelial features and are positive for keratin, epithelial membrane antigen, EGF receptor, and E cadherin. In contrast, fibroblast markers vimentin, desmin, and Factor VIII, were negative. Karyotyping showed losses of 6p, 7q, 8p, 18q, and 22q, and gains of 8q and 9q; additional genetic material was observed at 2q and 12p. CONCLUSION The PacMetUT1 cell line allows metastases to be assessed using a single animal model. Because of its slower growth, PacMetUT1 more closely mimics the human disease. Studies of tumor progression or metastasis can be conducted over a longer period of time. Prostate 68:883–892, 2008. © 2008 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>18361412</pmid><doi>10.1002/pros.20758</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0270-4137
ispartof The Prostate, 2008-06, Vol.68 (8), p.883-892
issn 0270-4137
1097-0045
language eng
recordid cdi_proquest_miscellaneous_69151148
source Wiley
subjects Cell Line, Tumor
Cell Proliferation
Cyclin-Dependent Kinase Inhibitor p21 - metabolism
Humans
Immunohistochemistry
Karyotyping
Male
metastasis
Middle Aged
Neoplasm Invasiveness
Neoplasm Metastasis
prostate cancer
prostate cancer cell lines
Prostatic Neoplasms - metabolism
Prostatic Neoplasms - pathology
Receptors, Androgen - metabolism
Transforming Growth Factor beta - pharmacology
Tumor Suppressor Protein p53 - metabolism
title Characterization of PacMetUT1, a recently isolated human prostate cancer cell line
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T22%3A16%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20of%20PacMetUT1,%20a%20recently%20isolated%20human%20prostate%20cancer%20cell%20line&rft.jtitle=The%20Prostate&rft.au=Troyer,%20D.A.&rft.date=2008-06-01&rft.volume=68&rft.issue=8&rft.spage=883&rft.epage=892&rft.pages=883-892&rft.issn=0270-4137&rft.eissn=1097-0045&rft_id=info:doi/10.1002/pros.20758&rft_dat=%3Cproquest_cross%3E69151148%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2958-8e6ada321ee44a9f99f2286d2c5f01bf261714af28c0b305be2a572bc8e886b93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69151148&rft_id=info:pmid/18361412&rfr_iscdi=true